BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36065977)

  • 1. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
    Brown RE; Chu L; Norman GJ; Abitbol A
    Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
    Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
    Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Zhou Y; Sardana D; Kuroko S; Haszard JJ; de Block MI; Weng J; Jefferies C; Wheeler BJ
    Diabet Med; 2024 Mar; 41(3):e15280. PubMed ID: 38197238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
    Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
    Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
    Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
    Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
    Jensen MH; Cichosz SL; Gustenhoff P; Nikontovic A; Hejlesen O; Vestergaard P
    PLoS One; 2022; 17(10):e0274626. PubMed ID: 36240184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 10. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time In Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World.
    Cherubini V; Bonfanti R; Casertano A; De Nitto E; Iannilli A; Lombardo F; Maltoni G; Marigliano M; Bassi M; Minuto N; Mozzillo E; Rabbone I; Rapini N; Rigamonti A; Salzano G; Scaramuzza A; Schiaffini R; Tinti D; Toni S; Zagaroli L; Zucchini S; Maffeis C; Gesuita R
    Diabetes Technol Ther; 2020 Jul; 22(7):509-515. PubMed ID: 32073311
    [No Abstract]   [Full Text] [Related]  

  • 12. The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    J Diabetes Sci Technol; 2024 May; 18(3):660-666. PubMed ID: 36172693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes.
    Yamada E; Nakajima Y; Horiguchi K; Okada S; Yamada M
    Endocr J; 2023 Dec; 70(12):1187-1193. PubMed ID: 37766568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
    Visser MM; Van Muylder A; Charleer S; Isitt JJ; Roze S; De Block C; Maes T; Vanhaverbeke G; Nobels F; Keymeulen B; Mathieu C; Luyten J; Gillard P; Verhaeghe N
    Diabetologia; 2024 Apr; 67(4):650-662. PubMed ID: 38236409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
    Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
    Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.
    Urakami T; Terada H; Yoshida K; Kuwabara R; Mine Y; Aoki M; Shoji Y; Suzuki J; Morioka I
    J Diabetes Investig; 2022 Oct; 13(10):1745-1752. PubMed ID: 35532954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
    Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades?
    Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A
    Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
    Leelarathna L; Sutton CJ; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Krishan A; Taxiarchi VP; Barnard-Kelly K; Elliott RA; Burns M; Camm M; Thabit H; Wilmot EG;
    Diabet Med; 2024 Mar; 41(3):e15249. PubMed ID: 37897112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.